Last updated: 11/07/2018 17:07:24
A double-blind, randomized, parallel group, multicenter, placebo-controlled clinical trial to evaluate the safety and efficacy of once-daily versus twice-daily intranasal administration of aqueous fluticasone propionate versus aqueous beclomethasone dipropionate in patients with perennial allerg ...
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A double-blind, randomized, parallel group, multicenter, placebo-controlled clinical trial to evaluate the safety and efficacy of once-daily versus twice-daily intranasal administration of aqueous fluticasone propionate versus aqueous beclomethasone dipropionate in patients with perennial allerg ...
Trial description: A double-blind, randomized, parallel group, multicenter, placebo-controlled clinical trial to evaluate the safety and efficacy of once-daily versus twice-daily intranasal administration of aqueous fluticasone propionate versus aqueous beclomethasone dipropionate in patients with perennial allerg ...
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
van As A, Bronsky E, Chervinsky P, et al. Fluticasone propionate once daily is as effective as beclomethasone dipropionate twice daily for perennial allergic rhinitis. J Allergy Clin Immunol 1991;87:154 (abstract)
van As A, Bronsky EA, Dockhorn RJ, et al. Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone dipropionate. J Allergy Clin Immunol 1993;91:1146-1154;
Medical condition
Rhinitis, Allergic, Perennial
Product
fluticasone propionate
Collaborators
Not applicable
Study date(s)
November 1988 to August 1990
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
1990-01-08
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website